A

ADC Therapeutics

322 employees

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Biopharma

Date founded

2011

Funding rounds raised

Total raised

$200M

from 9 investors over 9 rounds

A

ADC Therapeutics raised $76M on June 12, 2019

Investors: Auven Therapeutics and Redmile Group

A

ADC Therapeutics raised $200M on October 23, 2017

Investors: Redmile Group and Auven Therapeutics

A

ADC Therapeutics raised $105M on October 27, 2016

Investors: Auven Therapeutics

A

ADC Therapeutics raised $80M on September 2, 2015

Investors: Auven Therapeutics and EG Capital Advisors

A

ADC Therapeutics raised $40M on October 16, 2013

Investors: Auven Therapeutics

A

ADC Therapeutics raised $50M on March 26, 2012

Investors: Auven Therapeutics

FAQ